SPRO
Spero Therapeutics Inc
1.20$
-2.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62.5% | -23.8% | 141.2% | -183.8% | 94.8% | -155.6% | -68.1% | -149.9% | 571.6% | -21.1% | 6,148.8% | – | 45.6% | |
| 0.4% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | 0.0% | 0.0% | – | – | – | |
| 7.5% | 2.7% | 48.1% | 20.7% | 16.0% | 10.0% | 26.5% | 6.0% | 34.4% | 2.5% | 431.8% | – | 9.3% | |
| 45.4% | -96.5% | 388.4% | -31.9% | 204.1% | -28.5% | 136.8% | -143.9% | 750.9% | -103.6% | 8,421.3% | – | 15.5% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | |
| 0.9% | 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| 63.3% | -23.8% | 141.2% | -183.8% | 94.8% | -155.6% | -68.1% | -149.9% | 571.6% | -21.1% | 6,148.8% | – | 45.6% | |
| 62.5% | -23.8% | 141.2% | -183.8% | 94.8% | -155.6% | -68.1% | -149.9% | 571.6% | -21.1% | 6,148.8% | – | 45.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.